Over 10,000 results
Page 13 of 100
8-K
kks1xv 6vrq
3 Jun 24
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
8:20am
1-U
1o3uqlt6m
3 Jun 24
Current report (pursuant to Regulation A)
8:20am
6-K
bo7f9jbgi7jyriq36i
3 Jun 24
Current report (foreign)
8:19am
N-CSRS
bu2vpsg2v
3 Jun 24
Certified semi-annual shareholder report (management investment company)
8:19am
8-K
516 sampah
3 Jun 24
Regulation FD Disclosure
8:18am
8-K
ue0kjcgz8y ypmlt762q
3 Jun 24
FTAI Aviation Commences Cash Tender Offer for its 9.750% Senior Notes Due 2027
8:17am
10-12B/A
aewt5rhyq25
3 Jun 24
Registration of securities (amended)
8:17am
N-CSRS
afw1z
3 Jun 24
Certified semi-annual shareholder report (management investment company)
8:16am
FWP
nsx6vmjhq5i6sdoiv
3 Jun 24
Free writing prospectus
8:16am
8-K
cjn8b
3 Jun 24
Omega Provides an Update on the LaVie Restructuring
8:15am
SC 13G/A
9x3d5tk2iiijzel
3 Jun 24
Sky Harbour / Altai Capital Management ownership change
8:14am
8-K
lgut10hj6scktrhg
3 Jun 24
Molecular Templates, Inc. Provides Interim Update
8:13am
3
f3coc8r0bv8l cd3c7e
3 Jun 24
AUTOLIV / Staffan Olsson ownership change
8:12am
8-K
m09slxtqs xezzhza9iu
3 Jun 24
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
8:12am
8-K
0xbjvp8kt2h8zcabkg13
3 Jun 24
Entry into a Material Definitive Agreement
8:11am
8-K
lb011no43yoasoxkm a4
3 Jun 24
McKesson’s Board of Directors Elects Deborah Dunsire as New Director
8:08am
8-K
rrn0x9qdo
3 Jun 24
The Company is Actively Assessing Strategic Alternatives with Assistance from Roth Capital Partners, LLC
8:07am
8-K
c8d2v35d4df4w09yxo
3 Jun 24
Departure of Directors or Certain Officers
8:06am
8-K
dc1mc ah6az
3 Jun 24
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO
8:06am
6-K
7oap1abiy8req im1
3 Jun 24
Report of Foreign Private Issuer
8:05am